Delivery Order SPE2DB22D2007-SPE2DB24FJ3SJ

Award Date 6/26/24
Potential Completion Date 7/18/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,040.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Albumin (Human) 25% IV Solution, a critical medical product, with a performance period extending through May 13, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,005.20 firm-fixed-price delivery order is for the supply of Albumin (Human) 25% IV Solution, a pharmaceutical product used in medical care. The contract has an ultimate completion date of November 13, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of albumin (human) 25% intravenous solution in 50 ml vials. The contract, with a ceiling value of $3,618.72, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) on June 11, 2024, with a performance period through July 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a $1,668.10 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ALBUMIN (HUMAN) 25% IV SOLN 50ML. The contract has an ultimate completion date of June 20, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. This delivery order is part of a larger...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of albumin (human) 5% IV solution 250ml. The contract has a ceiling value of $1,456.80, a firm fixed price pricing type, and an ultimate completion date of August 7, 2024. This award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,552.78, is for the delivery of 100 ml bottles of 25% Albumin (Human) Intravenous Solution. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 250 ml intravenous (IV) solutions of 5% Human Albumin. The $1,821.00 contract has a completion date of January 11, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $36,553.21 delivery order contract is for the provision of pharmaceutical products and medical supplies, with a completion date of July 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to deliver a comprehensive range of medications,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $8,459.74 from the Defense Logistics Agency (DLA) Troop Support Medical for the provision of pharmaceutical products and medical supplies. The award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,510.74 for the supply of pharmaceutical products and medical supplies to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 10, 2024 and is a Firm Fixed Price agreement. Amerisourcebergen, a major pharmaceutical distribution company, holds an Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ3SJ
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,109.70 for the supply of Albumin (Human) 5% IV Solution 250ML to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 18, 2024 and was awarded on June 26, 2024 as a Firm Fixed Price contract.

Amerisourcebergen is a major pharmaceutical distribution company that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This specific contract award does not have a set-aside designation, indicating it was awarded through full and open competition. As a large pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government contracts for critical medical products.

Generated 9/25/24, 9:36 AM